Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Establishing a clinic-based pancreatic cancer and periampullary tumour research registry in Quebec.

Smith AL, Bascuñana C, Hall A, Salman A, Andrei AZ, Volenik A, Rothenmund H, Ferland D, Lamoussenery D, Kamath AS, Amre R, Caglar D, Gao ZH, Haegert DG, Kanber Y, Michel RP, Omeroglu-Altinel G, Asselah J, Bouganim N, Kavan P, Arena G, Barkun J, Chaudhury P, Gallinger S, Foulkes WD, Omeroglu A, Metrakos P, Zogopoulos G.

Curr Oncol. 2015 Apr;22(2):113-21. doi: 10.3747/co.22.2300.

2.

Naive CD4 T-cell activation identifies MS patients having rapid transition to progressive MS.

Zastepa E, Fitz-Gerald L, Hallett M, Antel J, Bar-Or A, Baranzini S, Lapierre Y, Haegert DG.

Neurology. 2014 Feb 25;82(8):681-90. doi: 10.1212/WNL.0000000000000146. Epub 2014 Jan 22. Erratum in: Neurology. 2014 Apr 1;82(13):1193.

3.

Castleman's Disease: a rare finding in a pediatric neck.

Zawawi F, Varshney R, Haegert DG, Daniel SJ.

Int J Pediatr Otorhinolaryngol. 2014 Feb;78(2):370-2. doi: 10.1016/j.ijporl.2013.11.015. Epub 2013 Nov 25. Review.

PMID:
24332608
4.

Multiple sclerosis: a disorder of altered T-cell homeostasis.

Haegert DG.

Mult Scler Int. 2011;2011:461304. doi: 10.1155/2011/461304. Epub 2011 Sep 15.

5.

Reduced thymic output and peripheral naïve CD4 T-cell alterations in primary progressive multiple sclerosis (PPMS).

Haegert DG, Hackenbroch JD, Duszczyszyn D, Fitz-Gerald L, Zastepa E, Mason H, Lapierre Y, Antel J, Bar-Or A.

J Neuroimmunol. 2011 Apr;233(1-2):233-9. doi: 10.1016/j.jneuroim.2010.12.007. Epub 2011 Jan 26.

PMID:
21272945
6.

Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients.

Johnson TA, Shames I, Keezer M, Lapierre Y, Haegert DG, Bar-Or A, Antel J.

Clin Immunol. 2010 Oct;137(1):15-20. doi: 10.1016/j.clim.2010.06.005.

PMID:
20599429
7.

Thymic involution and proliferative T-cell responses in multiple sclerosis.

Duszczyszyn DA, Williams JL, Mason H, Lapierre Y, Antel J, Haegert DG.

J Neuroimmunol. 2010 Apr 15;221(1-2):73-80. doi: 10.1016/j.jneuroim.2010.02.005. Epub 2010 Mar 12.

PMID:
20223525
8.

Altered naive CD4 and CD8 T cell homeostasis in patients with relapsing-remitting multiple sclerosis: thymic versus peripheral (non-thymic) mechanisms.

Duszczyszyn DA, Beck JD, Antel J, Bar-Or A, Lapierre Y, Gadag V, Haegert DG.

Clin Exp Immunol. 2006 Feb;143(2):305-13.

10.
11.

Identical twins discordant for multiple sclerosis have a shift in their T-cell receptor repertoires.

Haegert DG, Galutira D, Murray TJ, O'Connor P, Gadag V.

Clin Exp Immunol. 2003 Dec;134(3):532-7.

12.

The initiation of multiple sclerosis: a new infectious hypothesis.

Haegert DG.

Med Hypotheses. 2003 Feb;60(2):165-70.

PMID:
12606229
13.

Does a shift in the T-cell receptor repertoire precede the onset of MS?

Haegert DG, Cowan T, Murray TJ, Gadag V, O'Connor P.

Neurology. 1999 Aug 11;53(3):485-90.

PMID:
10449108
14.

Method of data analysis that elucidates contributions to the T-cell receptor repertoire.

Daniel ES, Gadag VG, Haegert DG.

Biotechniques. 1997 Jul;23(1):78-82. No abstract available.

15.

Quantitation of T-cell receptor transcripts using a wet agarose gel method.

Daniel ES, Haegert DG.

Biotechniques. 1996 Sep;21(3):374-6, 378. No abstract available.

16.

Method to identify biases in PCR amplification of T-cell receptor variable region genes.

Daniel ES, Haegert DG.

Biotechniques. 1996 Apr;20(4):600-2. No abstract available.

PMID:
8800677
17.

Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.

Haegert DG, Swift FV, Benedikz J.

Neurology. 1996 Apr;46(4):1107-11.

PMID:
8780100
18.

Genetic susceptibility to multiple sclerosis.

Haegert DG, Marrosu MG.

Ann Neurol. 1994 Dec;36 Suppl 2:S204-10. Review.

PMID:
7998789
19.

Absence of strong HLA-DR/DQ-DP linkage disequilibrium in the British and French Canadian Caucasoid populations.

Howell WM, Evans PR, Devereux SA, Sage DA, Smith JL, Haegert DG.

Eur J Immunogenet. 1993 Oct;20(5):363-71.

PMID:
9098404
20.
21.

HLA-DQA1 and -DQB1 associations with multiple sclerosis in Sardinia and French Canada: evidence for immunogenetically distinct patient groups.

Haegert DG, Muntoni F, Murru MR, Costa G, Francis GS, Marrosu MG.

Neurology. 1993 Mar;43(3 Pt 1):548-52.

PMID:
8450999
22.

Contribution of a single DQ beta chain residue to multiple sclerosis in French Canadians.

Haegert DG, Francis GS.

Hum Immunol. 1992 Jun;34(2):85-90.

PMID:
1429036
23.

Complications of immunosuppression associated with weekly low dose methotrexate.

Shiroky JB, Frost A, Skelton JD, Haegert DG, Newkirk MM, Neville C.

J Rheumatol. 1991 Aug;18(8):1172-5.

PMID:
1941818
24.

No association between susceptibility to multiple sclerosis and HLA-DPB1 alleles in the French Canadian population.

Howell WM, Sage DA, Evans PR, Smith JL, Francis GS, Haegert DG.

Tissue Antigens. 1991 Apr;37(4):156-60.

PMID:
1926123
25.

PCR-SSO typing for HLA-DPB alleles.

Howell WM, Sage DA, Haegert DG, Evans PR, Smith JL.

Eur J Immunogenet. 1991 Feb-Apr;18(1-2):81-95. No abstract available. Erratum in: Eur J Immunogen 1992 Jun;19(3):177.

PMID:
1676913
26.

Multiple sclerosis in French Canadians: evidence for HLA class II susceptibility and resistance genes.

Haegert DG, Michaud M, Francis GS.

Can J Neurol Sci. 1990 Nov;17(4):382-6.

PMID:
2125855
27.

Multiple sclerosis and HLA class II susceptibility and resistance genes.

Haegert DG, Michaud M, Schwab C, Francis GS.

J Neurosci Res. 1990 May;26(1):66-73.

PMID:
1972763
28.

HLA-DR beta, -DQ alpha, and -DQ beta restriction fragment length polymorphisms in multiple sclerosis.

Haegert DG, Michaud M, Schwab C, Tansey C, Décary F, Francis G.

J Neurosci Res. 1989 May;23(1):46-54.

PMID:
2568496
29.

Phenotypic and genotypic heterogeneity of peripheral T-cell lymphoma.

Smith JL, Haegert DG, Hodges E, Stacey GN, Howell WM, Wright DH, Jones DB.

Br J Cancer. 1988 Dec;58(6):723-9.

30.

Is HLA class II allogenotyping universally applicable?

Haegert DG, Michaud M, Schwab C.

Immunol Today. 1988 Sep;9(9):256-7. No abstract available.

PMID:
3255347
31.

Unexpected mAb reactivities in lymphoid neoplasia.

Haegert DG, Smith JL.

Immunol Today. 1988 Jul-Aug;9(7-8):193. No abstract available.

PMID:
3267133
32.

CD3+ CD8+ T cell lymphocytosis masking B cell leukaemia.

Smith JL, Oscier DG, Haegert DG, Jones DB, Howell M, Hodges E, Stevenson FK, Hamblin TJ.

J Clin Pathol. 1988 Jul;41(7):746-52.

33.
34.

Co-expression of surface immunoglobulin and T3 on hairy cells.

Haegert DG, Furlong MD, Smith JL.

Scand J Haematol. 1986 Sep;37(3):196-202.

PMID:
3097806
37.

Direct and mixed antiglobulin rosetting reaction.

Haegert DG.

Methods Enzymol. 1984;108:386-93. No abstract available.

PMID:
6335555
39.

T cell antigen receptors.

Haegert DG.

Anticancer Res. 1982 Jul-Aug;2(4):219-26. Review.

PMID:
6756284
40.

Rosette tests for T and B lymphocyte immunoglobulin.

Haegert DG.

Immunol Today. 1981 Oct;2(10):200-4. doi: 10.1016/0167-5699(81)90072-4.

PMID:
25290243
41.
43.
45.

Are most "null" cells B cells?

Haegert DG.

Lancet. 1980 Aug 9;2(8189):308. No abstract available.

PMID:
6105447
46.

Do human B and null lymphocytes form a single immunoglobulin-bearing population?

Haegert DG, Coombs RR.

Lancet. 1979 Nov 17;2(8151):1051-3.

PMID:
91787
49.

Demonstration of IgM receptors on human peripheral blood monocytes using a direct plaque forming cell (PFC) assay.

Haegert DG.

J Immunol Methods. 1979;28(1-2):97-104. No abstract available.

PMID:
381531
50.

Supplemental Content

Loading ...
Support Center